Compounds > fluorobenzenes
Page last updated: 2024-08-21

fluorobenzenes and Calcinosis

fluorobenzenes has been researched along with Calcinosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canziani, ME; Carvalho, AB; Christofalo, DM; Draibe, SA; Jancikic, AD; Lemos, MM; Sanches, FM; Watanabe, R1
Capoulade, R; Chan, KL; Clavel, MA; Côté, N; Després, JP; Dumesnil, JG; Mathieu, P; Pibarot, P; Tam, JW; Teo, KK1
Balog, C; Bayturan, O; Crowe, TD; Kapadia, S; Lavoie, A; Magyar, WA; Nicholls, SJ; Nissen, SE; Schoenhagen, P; Tuzcu, EM; Uno, K; Wolski, K1
Hong, MK; Kang, DH; Kim, JJ; Kim, YH; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW; Song, JK1
McDaniel, MC; Samady, H1
Budts, W; Cuypers, JA; Lindemans, J; Mulder, BJ; Pieper, PG; Roos-Hesselink, JW; Takkenberg, JJ; van der Burgh, PH; van der Linde, D; van Dijk, AP; Witsenburg, M; Yap, SC1
Barros, IM; Kristensen, SD; Moura, LM; Pinto, FJ; Ramos, SF; Rocha-Gonçalves, F1

Trials

6 trial(s) available for fluorobenzenes and Calcinosis

ArticleYear
Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study.
    Clinical nephrology, 2013, Volume: 80, Issue:1

    Topics: Adult; Aged; Analysis of Variance; Calcinosis; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Polyamines; Pyrimidines; Renal Insufficiency, Chronic; Rosuvastatin Calcium; Sevelamer; Sulfonamides; Tomography, X-Ray Computed

2013
Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
    JACC. Cardiovascular imaging, 2013, Volume: 6, Issue:2

    Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Canada; Chi-Square Distribution; Disease Progression; Female; Fluorobenzenes; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Insulin Resistance; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling

2013
Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.
    JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:7

    Topics: Aged; Atherosclerosis; Calcinosis; Disease Progression; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Predictive Value of Tests; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional

2009
Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.
    JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:7

    Topics: Aged; Calcinosis; Coronary Angiography; Coronary Artery Disease; Female; Fibrosis; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Necrosis; Predictive Value of Tests; Pyrimidines; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional; User-Computer Interface

2009
Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).
    The American journal of cardiology, 2011, Jul-15, Volume: 108, Issue:2

    Topics: Adolescent; Adult; Aortic Valve; Aortic Valve Stenosis; Belgium; Blood Flow Velocity; Calcinosis; Disease Progression; Double-Blind Method; Echocardiography, Doppler; Female; Fluorobenzenes; Follow-Up Studies; Heart Valve Prosthesis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Netherlands; Peptide Fragments; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Young Adult

2011
Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.
    The Journal of heart valve disease, 2012, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Calcinosis; Diastole; Disease Progression; Echocardiography; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure, Diastolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left

2012

Other Studies

2 other study(ies) available for fluorobenzenes and Calcinosis

ArticleYear
Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?
    JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:7

    Topics: Calcinosis; Coronary Artery Disease; Fatty Acids, Monounsaturated; Fibrosis; Fluorobenzenes; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Necrosis; Observer Variation; Predictive Value of Tests; Pyrimidines; Radiography; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional; User-Computer Interface

2009
Statins for aortic valve narrowing?
    Harvard heart letter : from Harvard Medical School, 2007, Volume: 17, Issue:8

    Topics: Aortic Valve Stenosis; Calcinosis; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2007